Maternal Plasma Plasminogen Activator Inhibitor-2 at 11 to 13 Weeks of Gestation in Hypertensive Disorders of Pregnancy

By Akolekar Ranjit   Cruz Jader De Jesus   Penco Jose Maria Perez   Zhou Yi   Nicolaides Kypros H.  

Hypertension in Pregnancy, Vol. 30, Iss. 2, 2011-05 ,pp. : 194-202

Informa Healthcare

Access to resources Recommend Favorite

Maternal Serum Human Placental Growth Hormone (hPGH) at 11 to 13 Weeks of Gestation in Preeclampsia

By Sifakis Stavros   Akolekar Ranjit   Mantas Nikitas   Kappou Dimitra   Nicolaides Kypros H.  

Hypertension in Pregnancy, Vol. 30, Iss. 1, 2011-02 ,pp. : 74-82

Informa Healthcare

Access to resources Recommend Favorite

Serum Lipid Levels at 28–32 Weeks Gestation and Hypertensive Disorders

By Ziaei Saeideh   Motlagh Bonab Khayyati   Kazemnejad Anoshirvan  

Hypertension in Pregnancy, Vol. 25, Iss. 1, 2006-05 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Alterations of maternal and fetal leptin concentrations in hypertensive disorders of pregnancy

By Vitoratos N.   Chrystodoulacos G.   Kouskouni E.   Salamalekis E.   Creatsas G.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 96, Iss. 1, 2001-05 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

Perinatal Outcomes Associated with Maternal Hypertensive Disorders of Pregnancy in a Developing Country

By Olusanya Bolajoko O.   Solanke Olumuyiwa A.  

Hypertension in Pregnancy, Vol. 31, Iss. 1, 2012-02 ,pp. : 120-130

Informa Healthcare

Access to resources Recommend Favorite